LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

Astellas

Status and phase: Completed; Phase 2

Conditions: Non-Small Cell Lung Carcinoma; Carcinoma, Non-Small Cell Lung; Cancer of the Lung; Cancer of Lung; Lung Cancer

Treatments: Drug: YM155

Study type: Interventional

Funder types: Industry

Identifiers

NCT00328588

155-CL-006

Details and patient eligibility

About

A study for the treatment of Non-Small Cell Lung Cancer (NSCLC) in patients previously treated with chemotherapy.

Enrollment: 37 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically or cytologically confirmed non-small cell lung cancer.
• Prior chemotherapy regimen(s) for lung cancer

Exclusion criteria

• History of other malignancy in the last 5 years
• Major surgery within the past 21 days

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

37 participants in 1 patient group

1

Experimental group

Description:

7 days continuous infusion

Treatment:

Drug: YM155